Stock Price
P/E Ratio
Volume Traded Today
Dividend
52 Week High/low
HealthEquity Inc Market Cap
Based on ratings from 12 stock analysts, the HealthEquity Inc stock price is expected to increase by 9.33% in 12 months. This is calculated by using the average 12-month stock price forecast for HealthEquity Inc. The lowest target is $77.00 and the highest is $110.00. Please note analyst price targets are not guaranteed and could be missed completely.
HQY is a stock in Consumer Discretionary which has been forecasted to be worth $88.92 as an average. On the higher end, the forecast price is $110.00 USD by jack wallace from Guggenheim and on the lower end HQY is forecasted to be $77.00 by cindy motz cfa from Goldman Sachs.
|
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
|---|---|---|---|---|
| allen lutz Bank of America Securities | Buy | $93.0 | reiterated | Feb 16, 2024 |
| stan berenshteyn Wells Fargo | Buy | $93.0 | maintained | Feb 14, 2024 |
| mark marcon Robert W. Baird | Buy | $92.0 | maintained | Jan 31, 2024 |
| stephanie davis Barclays | Buy | $84.0 | rated | Jan 23, 2024 |
| charles peters Raymond James | Buy | $95.0 | maintained | Dec 13, 2023 |
| anne samuel J.P. Morgan | Buy | $86.0 | maintained | Dec 13, 2023 |
| glen santangelo Jefferies | Buy | $79.0 | reiterated | Dec 11, 2023 |
| sean dodge RBC Capital | Buy | $77.0 | maintained | Dec 8, 2023 |
| scott schoenhaus KeyBanc | Buy | None | rated | Dec 7, 2023 |
| george hill Deutsche Bank | Buy | $88.0 | maintained | Dec 7, 2023 |
| alexander paris Barrington | Buy | $85.0 | reiterated | Dec 6, 2023 |
| jack wallace Guggenheim | Buy | $110.0 | reiterated | Dec 6, 2023 |
| david larsen BTIG | Buy | $85.0 | rated | Dec 5, 2023 |
| michael hartnett Bank of America Securities | Buy | $85.0 | reiterated | Mar 24, 2023 |
| sandy draper Guggenheim | Buy | $94.0 | reiterated | Mar 22, 2023 |
| cindy motz cfa Goldman Sachs | Hold | $77.0 | upgraded | Oct 21, 2022 |
| steven halper Cantor Fitzgerald | Buy | $85.0 | maintained | Jun 8, 2021 |
| dave larsen BTIG | Hold | None | initiatedcoverage | Jan 6, 2021 |
| jamie stockton Wells Fargo | Buy | $74.0 | maintained | Dec 8, 2020 |
| donald hooker KeyBanc | Hold | None | downgraded | Dec 2, 2020 |
HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is headquartered in Draper, Utah.
When did it IPO
2014
Staff Count
3,170
Country
United States
Sector/Industry
Healthcare/Health Information Services
CEO
Mr. Jon Kessler
Market Cap
$6.97B
In 2023, HQY generated $0 in revenue, which was a increase of 0.00% from the previous year. This can be seen as a signal that HQY's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2019
Revenue From 2020
Revenue From 2021
Revenue From 2022
CROX-USD
$115.72
LSTR-USD
$194.21
CHRD-USD
$162.86
HAS-USD
$50.19
ENSG-USD
$122.93
ALTR-USD
$89.86
The information that Ticker Nerd provides is general in nature as it has been prepared without taking account of your objectives, financial situation or needs. It is not intended as legal, financial or investment advice and should not be construed or relied on as such. Ticker Nerd is for information purposes only. Ticker Nerd is not responsible for any damages or losses that may occur as a result of reliance on this information. Before making any commitment of a legal or financial nature you should seek advice from a qualified and registered legal practitioner or financial or investment adviser. All content, group, messaging, tweets, newsletter, article, and email created by Ticker Nerd is intended for educational and information purposes only, is not financial, investment, legal or tax advice, and is a restatement, summary or extract of other data and research reports that are widely distributed from sources such as, but not limited to, Bloomberg, Market Watch, Wall Street Journal, Google Finance, and Yahoo Finance. Ticker Nerd is not a registered financial, investment, legal or tax advisor and is not liable for any financial loss you may incur acting on any information provided by Ticker Nerd. By registering, you agree not to hold Ticker Nerd liable at any time or under any circumstances for your decisions, actions, or results.
